These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 35793053)

  • 41. Baseline preferences for oral pre-exposure prophylaxis (PrEP) or dapivirine intravaginal ring for HIV prevention among adolescent girls and young women in South Africa, Uganda and Zimbabwe (MTN-034/IPM-045 study).
    Ngure K; Friedland BA; Szydlo DW; Roberts ST; Garcia M; Levy L; Akello CA; Reddy K; Palanee-Phillips T; Macdonald P; Siziba B; Soto-Torres L; Hosek S; Hillier SL; Nair G; Celum C; van der Straten A
    PLoS One; 2023; 18(6):e0287525. PubMed ID: 37352296
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Trajectories of PrEP Adherence Among Young Women Aged 16 to 25 in Cape Town, South Africa.
    Stoner MCD; Rucinski KB; Giovenco D; Gill K; Morton JF; Bekker LG; Celum CL; van der Straten A
    AIDS Behav; 2021 Jul; 25(7):2046-2053. PubMed ID: 33389323
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antiretroviral therapy based HIV prevention targeting young women who sell sex: a mixed method approach to understand the implementation of PrEP in a rural area of KwaZulu-Natal, South Africa.
    Chimbindi N; Mthiyane N; Zuma T; Baisley K; Pillay D; McGrath N; Harling G; Sherr L; Birdthistle I; Floyd S; Dreyer J; Nakasone S; Seeley J; Shahmanesh M
    AIDS Care; 2022 Feb; 34(2):232-240. PubMed ID: 33769156
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oral pre-exposure prophylaxis preference, uptake, adherence and continuation among adolescent girls and young women in Kampala, Uganda: a prospective cohort study.
    Mayanja Y; Kamacooko O; Lunkuse JF; Muturi-Kioi V; Buzibye A; Omali D; Chinyenze K; Kuteesa M; Kaleebu P; Price MA
    J Int AIDS Soc; 2022 May; 25(5):e25909. PubMed ID: 35543110
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multi-level Interventions to Promote Oral Pre-exposure Prophylaxis Use Among Adolescent Girls and Young Women: a Review of Recent Research.
    Irungu E; Khoza N; Velloza J
    Curr HIV/AIDS Rep; 2021 Dec; 18(6):490-499. PubMed ID: 34719745
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The PrEPARE Pretoria Project: protocol for a cluster-randomized factorial-design trial to prevent HIV with PrEP among adolescent girls and young women in Tshwane, South Africa.
    Wechsberg WM; Browne FA; Ndirangu J; Bonner CP; Minnis AM; Nyblade L; Speizer IS; Howard BN; Myers B; Ahmed K
    BMC Public Health; 2020 Sep; 20(1):1403. PubMed ID: 32933510
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Incremental costs of integrated PrEP provision and effective use counselling in community-based platforms for adolescent girls and young women in South Africa: an observational study.
    Mudimu E; Sardinia J; Momin S; Medina-Marino A; Bezuidenhout C; Bekker LG; Barnabas RV; Peebles K
    J Int AIDS Soc; 2022 Feb; 25(2):e25875. PubMed ID: 35129299
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preventing HIV among adolescents with oral PrEP: observations and challenges in the United States and South Africa.
    Hosek S; Celum C; Wilson CM; Kapogiannis B; Delany-Moretlwe S; Bekker LG
    J Int AIDS Soc; 2016; 19(7(Suppl 6)):21107. PubMed ID: 27760684
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Awareness of Heightened Sexual and Behavioral Vulnerability as a Trigger for PrEP Resumption Among Adolescent Girls and Young Women in East and Southern Africa.
    Reddy K; Palanee-Phillips T; Heffron R
    Curr HIV/AIDS Rep; 2023 Dec; 20(6):333-344. PubMed ID: 38051383
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PrEP implementation research in Africa: what is new?
    Cowan FM; Delany-Moretlwe S; Sanders EJ; Mugo NR; Guedou FA; Alary M; Behanzin L; Mugurungi O; Bekker LG
    J Int AIDS Soc; 2016; 19(7(Suppl 6)):21101. PubMed ID: 27760680
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The PrEP Journey: Understanding How Internal Drivers and External Circumstances Impact The PrEP Trajectory of Adolescent Girls and Young Women in Cape Town, South Africa.
    O'Rourke S; Hartmann M; Myers L; Lawrence N; Gill K; Morton JF; Celum CL; Bekker LG; van der Straten A
    AIDS Behav; 2021 Jul; 25(7):2154-2165. PubMed ID: 33521908
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Key influences on the decision to initiate PrEP among adolescent girls and young women within routine maternal child health and family planning clinics in Western Kenya.
    Rogers Z; Pintye J; Kinuthia J; O'Malley G; Abuna F; Escudero J; Mugambi M; Awuor M; Dollah A; Dettinger JC; Kohler P; John-Stewart G; Beima-Sofie K
    AIDS Care; 2022 Mar; 34(3):363-370. PubMed ID: 34543077
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HIV prevention at drug shops: awareness and attitudes among shop dispensers and young women about oral pre-exposure prophylaxis and the dapivirine ring in Shinyanga, Tanzania.
    Tubert J; Packel L; Hunter LA; Mfaume R; Njau P; Ramadhani AA; Liu JX; McCoy SI
    AIDS Res Ther; 2021 Apr; 18(1):21. PubMed ID: 33902623
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A decision support tool has similar high PrEP uptake and increases early PrEP persistence in adolescent girls and young women in South Africa: results from a randomized controlled trial.
    Celum C; Seidman D; Travill D; Dehlendorf C; Gumede S; Zewdie K; Wilson W; Morton JF; Baeten JM; Donnell D; Delany-Moretlwe S
    J Int AIDS Soc; 2023 Aug; 26(8):e26154. PubMed ID: 37634942
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    Vera M; Bukusi E; Achieng P; Aketch H; Araka E; Baeten JM; Beima-Sofie K; John-Stewart G; Kohler PK; Mugambi ML; Nyerere B; Odoyo J; Omom C; Omondi C; Ortblad KF; Pintye J
    J Int Assoc Provid AIDS Care; 2023; 22():23259582231215882. PubMed ID: 37997351
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preference for novel biomedical HIV pre-exposure prophylaxis methods among adolescent girls and young women in Kampala, Uganda: a mixed methods study.
    Mayanja Y; Kayesu I; Kamacooko O; Lunkuse JF; Muturi-Kioi V; Price M; Kosidou K; Ekström AM
    Front Public Health; 2024; 12():1369256. PubMed ID: 38846614
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Experiences of oral pre-exposure prophylaxis use among heterosexual men accessing sexual and reproductive health services in South Africa: a qualitative study.
    Cholo FA; Dada S; Martin CE; Mullick S
    J Int AIDS Soc; 2024 May; 27(5):e26249. PubMed ID: 38695102
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Women's Perceptions of HIV- and Sexuality-Related Stigma in Relation to PrEP: Qualitative Findings from the Masibambane Study, Durban, South Africa.
    Bergam S; Harrison AD; Benghu N; Khumalo S; Tesfay N; Exner T; Miller L; Dolezal C; Hanass-Hancock J; Hoffman S
    AIDS Behav; 2022 Sep; 26(9):2881-2890. PubMed ID: 35218452
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Low awareness of oral and injectable PrEP among high-risk adolescent girls and young women in Kampala, Uganda.
    Lunkuse JF; Kamacooko O; Muturi-Kioi V; Chinyenze K; Kuteesa MO; Price MA; Mayanja Y
    BMC Infect Dis; 2022 May; 22(1):467. PubMed ID: 35578163
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adolescent girls and young women's PrEP-user journey during an implementation science study in South Africa and Kenya.
    Rousseau E; Katz AWK; O'Rourke S; Bekker LG; Delany-Moretlwe S; Bukusi E; Travill D; Omollo V; Morton JF; O'Malley G; Haberer JE; Heffron R; Johnson R; Celum C; Baeten JM; van der Straten A
    PLoS One; 2021; 16(10):e0258542. PubMed ID: 34648589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.